Market Capitalization (Millions $) |
200 |
Shares
Outstanding (Millions) |
55 |
Employees |
- |
Revenues (TTM) (Millions $) |
3 |
Net Income (TTM) (Millions $) |
-108 |
Cash Flow (TTM) (Millions $) |
5 |
Capital Exp. (TTM) (Millions $) |
2 |
Omega Therapeutics Inc
Omega Therapeutics Inc is a biotechnology company focused on developing therapies that target the human genome to treat various diseases. The company utilizes a novel approach called epigenomic programming, which involves modifying the gene expression patterns in cells to restore normal cellular function. Omega Therapeutics' therapies have the potential to address a wide range of diseases, including genetic disorders, cancer, and autoimmune conditions. The company aims to revolutionize the field of gene therapy and improve patient outcomes by targeting the underlying cause of diseases at the genetic level.
Company Address: 140 First StreetSuite 501 Cambridge 2141 MA
Company Phone Number: 949-4360 Stock Exchange / Ticker: NASDAQ OMGA
|